Sort
34,240 grants matching “atherosclerosis”
Phage-based targeted imaging probes and their application to vascular diseases
$668,540Trevor Douglas · Trustees Of Indiana University · R01 · FY2014 · EB
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.
$668,481Thomas None Quertermous · Stanford University · R01 · FY2021 · HL
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV Infection
$668,476Peter W Hunt · University Of California, San Francisco · R01 · FY2021 · HL
Phage-based targeted imaging probes and their application to vascular diseases
$668,448Trevor Douglas · Montana State University - Bozeman · R01 · FY2011 · EB
A Receptor-Targeted Nanoparticle PET Tracer in Human Carotid Atherosclerosis
$668,436Pamela K Woodard · Washington University · R01 · FY2024 · HL
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$668,427Pal Pacher · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA
Metabolic Regulation of Inflammatory Immune Responses in Cardiovascular Disease
$668,159Cornelia M Weyand · Vanderbilt University Medical Center · P01 · FY2018 · HL
Metabolic Regulation of Inflammatory Immune Responses in Cardiovascular Disease
$668,159Cornelia M Weyand · Vanderbilt University Medical Center · P01 · FY2020 · HL
Metabolic Regulation of Inflammatory Immune Responses in Cardiovascular Disease
$668,159Cornelia M Weyand · Vanderbilt University Medical Center · P01 · FY2019 · HL
Metabolic Regulation of Inflammatory Immune Responses in Cardiovascular Disease
$668,159Cornelia M Weyand · Vanderbilt University Medical Center · P01 · FY2017 · HL
Evaluating the role of multimorbidity in modulation medication effects in older adults
$668,085Chintan Dave · Rutgers Biomedical And Health Sciences · R01 · FY2024 · HL
Community Translation of the South Asian Healthy Lifestyle Intervention (SAHELI)
$667,944Namratha R Kandula · Northwestern University At Chicago · R01 · FY2021 · HL
Using Fortilin Inhibitors to Block Atherosclerosis
$667,812Ken Fujise · University Of Texas Med Br Galveston · R01 · FY2019 · HL
Dissecting the role of CD8+ T cells in atherosclerosis
$667,760Chiara Giannarelli · New York University School Of Medicine · R01 · FY2022 · HL
Chemically inducible split base editors for precise and controllable in vivo genome editing
$667,704Xue Gao · University Of Pennsylvania · R01 · FY2025 · HL
Airway trees in the Anthropocene: Defining resilient airway trees and identifying the candidate mechanisms and etiologic factors that increase susceptibility to tobacco smoke and air pollution
$667,649Benjamin M. Smith · Columbia University Health Sciences · R01 · FY2024 · HL
Enhancing Support for Women w/Type 2 Diabetes: Follow-Up
$667,624Deborah J Toobert · Oregon Research Institute · R01 · FY2007 · HL
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.
$667,612Thomas None Quertermous · Stanford University · R01 · FY2023 · HL
Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway.
$667,612Thomas None Quertermous · Stanford University · R01 · FY2022 · HL
Genetics of Coronary Artery Disease in Alaska Natives
$667,556Anthony G. Comuzzie · Texas Biomedical Research Institute · U01 · FY2009 · HL
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$667,188Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
Assessing Long Term Outcomes of Living Donation
$667,100Bertram L Kasiske · University Of Minnesota · U01 · FY2014 · DK
High Frame Rate 3-D Super Resolution Ultrasound Microvascular Imaging
$667,090Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Multi-Omics and Chronic Kidney Disease: Correlation with Histology
$667,051Morgan Erika Grams · New York University School Of Medicine · R01 · FY2025 · DK
Bayesian machine learning for causal inference with incomplete longitudinal covariates and censored survival outcomes
$666,796Liangyuan Hu · Rutgers Biomedical And Health Sciences · R01 · FY2023 · HL